07 Jan 2001

codi OPT® (codi OPT® Tabletten) - Deutschland

codi OPT® Description, Presentation and Dosage

codi OPT® Description

codi OPT® Drug Class Description

Morphin u. Derivate

codi OPT® Drug Description

1 Tbl. enth.: Codeinphosphat ½H2O 76,82 mg (entspr. 56,53 mg Codeinbase).

codi OPT® Generic Name

codi OPT® Tabletten

codi OPT® Presentation

codi OPT® Presentation

codi OPT®

codi OPT® Manufacturer

Optimed

Related Learning Zones

Cystic Fibrosis Knowledge Centre

Cystic Fibrosis Knowledge Centre

Cystic fibrosis (CF) is a genetic condition caused by a defect in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel. The Cystic Fibrosis Knowledge Centre provides healthcare professionals with access to disease awareness information, emerging and established treatment options and current best practice based on recently updated guidelines by the European Cystic Fibrosis Society (ECFS). A resources section contains external links to upcoming medical conferences and patient support groups.

This resource is developed by EPG Health Media for epgonline.org, supported by an independent educational grant from Vertex.

Symptomatic Asthma Knowledge Centre and CME

Symptomatic Asthma Knowledge Centre and CME

Focusing on the lack of symptomatic control in patients with asthma, the new Symptomatic Asthma Learning Zone, consisting of a Disease Awareness section and an RCGP-accredited CME, is free to access for all epgonline.org members, and has been designed to provide them with the information they need to effectively manage the symptoms of their patients with asthma.

codi OPT® Dosage

codi OPT® Adult Dosage

Crospovidon, Lactose 1H2O, Magnesiumstearat, Povidon.

codi OPT® Precautions, Reactions and Contraindications

codi OPT® Special Precautions

codi OPT® Special Precautions

C 85 a-c

codi OPT® Adverse Reactions

codi OPT® Adverse Reactions

C 85

Related Drugs - Pain Management

Back to top